Scarlet Therapeutics ("Scarlet") today announces a landmark preclinical result: its proprietary cell-line derived, universal, lab-grown red blood cells (“RBCs”) have successfully matured and ...
Scarlet Therapeutics Ltd. has demonstrated its manufactured red blood cells (RBCs) act in the same way as their natural counterparts in vivo, opening the way for the cells to be used as drug delivery ...
Johns Hopkins APL researchers are investigating the viability and scalability of shelf-stable, freeze-dried red blood cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results